Go back to News
NEWS
Generative AI: ethical and legal implications of synthetic content creation | Harvard Deusto
4 of May, 2023
Harvard Deusto has published in its monthly magazine this article prepared by our professionals, Isabel Bandín and Carlos Álvarez, in which they give their opinion on the boom in the development of generative artificial intelligence, a new model designed to generate synthetic data based on patterns learned from existing data.
Read the full article.
Read the full article.
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
3 days ago 
PUBLICATION
Intellectual property, text and data mining and artificial intelligence training
The problem consisting of the use of works and other protected subject matter for the purposes of mining and training of artificial intelligence is analysed in the light of the judgment of the Regional Court of Hamburg of 27 September 2024 (310 O 227/23).
30 Oct, 2024 
PUBLICATION
Pharma & Healthcare No. 40
25 Sep, 2024
PUBLICATION
Digital Content and Services – New consumers and users’ rights
Last week on 27 April, Royal Decree-act 7/2021 of 27 April on the transposition of European Union directives on competition, prevention of money laundering, credit institutions, telecommunications, tax measures, prevention and repair of environmental damage, movement of employees in the provision of transnational services and consumer defence (“RDL 7/2021”).
18 May, 2021
PUBLICATION
Life Sciences Newsletter No. 9
OJ L 115 of 4 May 2018 publishes Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018R0669&from=EN
01 Aug, 2018
PUBLICATION
Publicidad de medicamentos, ficha técnica y menciones distintas de las indicaciones terapéuticas
Al hilo de la Sentencia núm. 186/2018 de la Audiencia Provincial de Barcelona (Sección 15.ª) se examina tanto la necesidad de que la publicidad de los medicamentos se ajuste a la ficha técnica como la posibilidad de incluir en el mensaje publicitario menciones distintas de las indicaciones terapéuticas del medicamento.
16 Jul, 2018
PUBLICATION
Current Legislation No. 24
GA_P’s Current Legislation digests seek to provide an overview of the main legal issues of interest to our readers, clients and lawyers in a format that combines three elements: topicality, clarity and quality. Topicality in the information and in the selection of matters discussed; clarity in laying the foregoing in a concise and intelligible manner rather than...
10 Jul, 2018
PUBLICATION
¿Qué sector de público hay que tener en cuenta para determinar si se ha vulgarizado una marca farmacéutica?
1. La vulgarización como causa de caducidad de una marca 1.1. Una de las causas de caducidad de una marca que se prevén en las legislaciones europea y española es la de la conversión del signo que conforma la marca en la designación usual de un producto o de un servicio para el que está...
04 Jun, 2018